Altamira Therapeutics
CYTO
#8281
Rank
$3.62 M
Marketcap
🇧🇲 Bermuda
Country
$1.62
Share price
0.00%
Change (1 day)
97.56%
Change (1 year)
Categories
Operating Margin for Altamira Therapeutics (CYTO)
Operating Margin at the end of 2021: -26,891.54%
According to Altamira Therapeutics's latest financial reports and stock price the company's current Operating Margin is -26,891.50%. At the end of 2021 the company had an Operating Margin of -26,891.54%.
Operating Margin history for Altamira Therapeutics from 2020 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -26,891.54% | 480.23% |
| 2020 | -4,634.65% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.